clsi recommendations Search Results


clsi/ifcc recommended population size  (International Federation of Clinical Chemistry and Laboratory Medicine)
90
International Federation of Clinical Chemistry and Laboratory Medicine clsi/ifcc recommended population size
Clsi/Ifcc Recommended Population Size, supplied by International Federation of Clinical Chemistry and Laboratory Medicine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clsi/ifcc recommended population size/product/International Federation of Clinical Chemistry and Laboratory Medicine
Average 90 stars, based on 1 article reviews
clsi/ifcc recommended population size - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
clsi-recommended double-disk method  (Becton Dickinson)
90
Becton Dickinson clsi-recommended double-disk method
Clsi Recommended Double Disk Method, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clsi-recommended double-disk method/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
clsi-recommended double-disk method - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
clsi break point recommendations for extended-spectrum cephalosporins and carbapenems  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute clsi break point recommendations for extended-spectrum cephalosporins and carbapenems
Trends of selected antimicrobial susceptibilities for Escherichia coli isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) <t>Carbapenems,</t> B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Fluoroquinolones. Error bars indicate 95% CIs.
Clsi Break Point Recommendations For Extended Spectrum Cephalosporins And Carbapenems, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clsi break point recommendations for extended-spectrum cephalosporins and carbapenems/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
clsi break point recommendations for extended-spectrum cephalosporins and carbapenems - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
clsi recommended doubling technique  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute clsi recommended doubling technique
Trends of selected antimicrobial susceptibilities for Escherichia coli isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) <t>Carbapenems,</t> B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Fluoroquinolones. Error bars indicate 95% CIs.
Clsi Recommended Doubling Technique, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clsi recommended doubling technique/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
clsi recommended doubling technique - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
clsi recommended standard medicine-sensitive experiment procedure  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute clsi recommended standard medicine-sensitive experiment procedure
Trends of selected antimicrobial susceptibilities for Escherichia coli isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) <t>Carbapenems,</t> B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Fluoroquinolones. Error bars indicate 95% CIs.
Clsi Recommended Standard Medicine Sensitive Experiment Procedure, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clsi recommended standard medicine-sensitive experiment procedure/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
clsi recommended standard medicine-sensitive experiment procedure - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
clsi recommended methodologies  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute clsi recommended methodologies
Trends of selected antimicrobial susceptibilities for Escherichia coli isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) <t>Carbapenems,</t> B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Fluoroquinolones. Error bars indicate 95% CIs.
Clsi Recommended Methodologies, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clsi recommended methodologies/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
clsi recommended methodologies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
clsi recommendation for filamentous fungi  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute clsi recommendation for filamentous fungi
Trends of selected antimicrobial susceptibilities for Escherichia coli isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) <t>Carbapenems,</t> B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Fluoroquinolones. Error bars indicate 95% CIs.
Clsi Recommendation For Filamentous Fungi, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clsi recommendation for filamentous fungi/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
clsi recommendation for filamentous fungi - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Trends of selected antimicrobial susceptibilities for Escherichia coli isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) Carbapenems, B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Fluoroquinolones. Error bars indicate 95% CIs.

Journal: Emerging Infectious Diseases

Article Title: Antimicrobial Nonsusceptibility of Gram-Negative Bloodstream Isolates, Veterans Health Administration System, United States, 2003–2013 1

doi: 10.3201/eid2311.161214

Figure Lengend Snippet: Trends of selected antimicrobial susceptibilities for Escherichia coli isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) Carbapenems, B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Fluoroquinolones. Error bars indicate 95% CIs.

Article Snippet: Third, the Clinical and Laboratory Standards Institute (CLSI) revised its break point recommendations for extended-spectrum cephalosporins and carbapenems in 2010 , and antimicrobial susceptibility trends in the later part of the study might have been affected by this change.

Techniques:

Trends of selected antimicrobial susceptibilities for Klebsiella spp. isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) Carbapenems, B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Fluoroquinolones. Error bars indicate 95% CIs.

Journal: Emerging Infectious Diseases

Article Title: Antimicrobial Nonsusceptibility of Gram-Negative Bloodstream Isolates, Veterans Health Administration System, United States, 2003–2013 1

doi: 10.3201/eid2311.161214

Figure Lengend Snippet: Trends of selected antimicrobial susceptibilities for Klebsiella spp. isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) Carbapenems, B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Fluoroquinolones. Error bars indicate 95% CIs.

Article Snippet: Third, the Clinical and Laboratory Standards Institute (CLSI) revised its break point recommendations for extended-spectrum cephalosporins and carbapenems in 2010 , and antimicrobial susceptibility trends in the later part of the study might have been affected by this change.

Techniques:

Trends of selected antimicrobial susceptibilities for Pseudomonas aeruginosa isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) Antipseudomonal carbapenems, B) Antipseudomonal cephalosporins, C) Aminoglycosides, D) Antipseudomonal fluoroquinolones. Error bars indicate 95% CIs.

Journal: Emerging Infectious Diseases

Article Title: Antimicrobial Nonsusceptibility of Gram-Negative Bloodstream Isolates, Veterans Health Administration System, United States, 2003–2013 1

doi: 10.3201/eid2311.161214

Figure Lengend Snippet: Trends of selected antimicrobial susceptibilities for Pseudomonas aeruginosa isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) Antipseudomonal carbapenems, B) Antipseudomonal cephalosporins, C) Aminoglycosides, D) Antipseudomonal fluoroquinolones. Error bars indicate 95% CIs.

Article Snippet: Third, the Clinical and Laboratory Standards Institute (CLSI) revised its break point recommendations for extended-spectrum cephalosporins and carbapenems in 2010 , and antimicrobial susceptibility trends in the later part of the study might have been affected by this change.

Techniques:

Trends of selected antimicrobial susceptibilities for Acinetobacter spp. isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) Antipseudomonal carbapenems, B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Antipseudomonal fluoroquinolones. Error bars indicate 95% CIs.

Journal: Emerging Infectious Diseases

Article Title: Antimicrobial Nonsusceptibility of Gram-Negative Bloodstream Isolates, Veterans Health Administration System, United States, 2003–2013 1

doi: 10.3201/eid2311.161214

Figure Lengend Snippet: Trends of selected antimicrobial susceptibilities for Acinetobacter spp. isolates from patients with bacteremia, Veterans Health Administration System, United States, 2003–2013. A) Antipseudomonal carbapenems, B) Extended-spectrum cephalosporins, C) Aminoglycosides, D) Antipseudomonal fluoroquinolones. Error bars indicate 95% CIs.

Article Snippet: Third, the Clinical and Laboratory Standards Institute (CLSI) revised its break point recommendations for extended-spectrum cephalosporins and carbapenems in 2010 , and antimicrobial susceptibility trends in the later part of the study might have been affected by this change.

Techniques: